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Introduction 1
Epiphyseal cartilage of long bone is destined to develop to bone with marrow cavity and 2 articular cartilage. The epiphyseal cartilage continues to proliferate and undergoes 3 enchondral ossification until apparent growth ceases at adolescence, and eventually is 4 replaced with bone except for articular surface which remains cartilaginous throughout 5 life [1] . Chondrocytes in culture have an ability to generate cartilage in vivo, and can be 6 a tool to simulate developmental process. Our previous study demonstrated that human 7 infant epiphyseal chondrocytes can also simulate developmental process of epiphyseal 8 cartilage as well as other cell types [2, 3] . Chondrocytes in culture regenerate the 9 cartilaginous tissue by a short-term implantation in vivo and exhibited enchondral 10 ossification after a longer period. The cell-based therapeutic strategies in cartilage and 11 bone require serial cell passage of expanded chondrocytes for acquisition of a large 12 number of cells. In this study, we extensively characterized chondrocytes derived from 13 human epiphyseal cartilage in correlation with regenerative medicine. 14 15
Materials and Methods 16
Human epiphyseal chondrocytes (HECs) 17
HECs were obtained from epiphyseal cartilage of the phalanx and metacarpal bones of 18 amputated supernumerary digitus with polydactyly of finger or toe of 5 patients 19 (patient's age 7-14 months). Signed informed consents were obtained from the parents 20 of the donors. Isolation of HECs was performed as described previously [2] . Briefly, 21 after confirmation of no development of secondary ossification center in the epiphyseal 22 ends of bone, the epiphyseal cartilage was dissected out from bones and cut into piece 23 of 1 mm 3 . The diced fragments were placed in 0.2% trypsin/0.02% EDTA solution 24 1 of endogenous peroxidase by 1% hydrogen peroxide/methanol for 15 min, the sections 2 were incubated at room temperature for 60 min in primary antibodies diluted with 3 antibody diluent (Dako). The sections were washed with 0.01 M Tris buffered saline 4 (TBS) solution (pH 7.4) and incubated with goat anti-mouse and anti-rabbit 5 immunoglobulin labeled with dextran molecules-horseradish peroxidase (EnVision, 6 Dako) for 30 min at room temperature. After washing with TBS, the sections were 7 incubated in 3,3'-diaminobenzidin in substrate-chromogen solution (Dako) for 5-10 min. 8 Negative controls were performed by omitting the primary antibody. The sections were 9 counterstained with hematoxylin. 10 11 Results 12
HEC in culture 13
HECs were fibroblast-like in morphology at a primary culture. HECs slowly 14 proliferated until 4th day after start of the cultivation, and then rapidly proliferated at 15 5-6th day ( Figure 1A ). The cells reached to senescence before PDL 60. PDLs of the 16 senesced cells were 52.4 in an average at Passage 8. We then examined HECs for 17 expression of cartilage-associated genes at each passage by RT-PCR analysis (Figure  18 1B). The type-II collagen gene was expressed at P0 and P1, but was not detected at P2 19 to P8. The genes for collagen type I, III and X remained to be expressed from P0 to P8. 20 21 HECs showed extensive morphological alternations during passage expansions ( Figure  22 2): P0, small polygonal cells with many mitoses; P1 and P2, bipolar elongated spindle 23 cells; P3-P5, bipolar short spindle cells of with appearance of large cells; P6-P8, large, 24 7 fusiform or polygonal cells with long cytoplasmic processes, indistinct nuclear 1 chromatin structures and occasional vacuolations. P8 cells became enlarged and deeply 2 stained with senescence-associated ß-galactosidase. 3 4 Implantation of HECs for two weeks 5
We subcutaneously implanted HECs at each passage to investigate ability of 6 chondrogenesis and osteogenesis in vivo. P0 and P1 cells generated the nodules that 7 hardly changed in size, weight and in degree of transparency with whitish color on 8 surface ( Figure 2 ). In contrast, P2 cells foamed the nodules that decreased in weight, 9 size and degree of transparency. The nodule by P0 cells was clearly divided into two 10 different parts, cartilage composing of chondrocytes with lacunae and abundant 11 extracellular matrix in the center, and perichondrium with spindle cells-layers at the 12 periphery ( Figure 3 ), as demonstrated in the previous study [2] . Extracellular matrix in 13 the cartilage generated by P0 and P1 cells demonstrated metachromasia with Toluidine 14 Blue stain. Vimentin was detected in both chondrocytes and perichondral spindle cells. 15
Type II collagen-positive matrix was diffusely distributed in the cartilage by P0 and P1 16 cells, and type I collagen-positive matrix was localized in the perichondrium. 17 18 Unlike P0, P1 and P2 cells, P3 to P8 cells generated small and flattened nodules without 19 clear vascular invasion on opaque, whitish to brownish surface color, and failed to 20 generate cartilage. Microscopically, the nodules showed fibrous tissues with lack of 21 chondrocytes with lacunae, and the increase of spindle and dedifferentiated 22 chondrocytes. The fibrous tissue included inflammatory cells, reactions of foreign-body 23 giant cells and vascular invasions. 24 1
Long-term observation of cartilage and bone by P0 to P2 HEC implantation 2
We then followed up the nodule of bone and cartilage following implantation of HEC at 3 P0 (PDL 7) until 20 and 40 weeks ( Figure 4) . Macroscopically, the nodules showed 4 smooth surface with white-yellow and reddish portion in color at 20 weeks and 40 5 weeks. Enchondral ossification progressed in the cartilage at 20 weeks and new bone 6 and marrow cavity were formed ( Figure 4A At 20 weeks, type II collagen was detected in the extracellular matrix of cartilage, but 15 gradually reduced ( Figure 4E ). In contrast, type I collagen became positive in matrix of 16 osteoid, new bone and periosteum ( Figure 4F ). The CD 31-positive endothelial cells 17 were present along with the vessels at the periphery of cartilage ( Figure 4G ). At 40 18 weeks, type II collagen remained positive in peripheral cartilage and occasionally in 19 core of enchondral ossification ( Figure 4M, N) . Type I collagen-positive matrix was 20 clearly distributed in trabecular bone ( Figure 4O , P). The vasculogenesis with CD 21 31-positive endothelial cells became prominent ( Figure 4Q ). 22
23
We then investigated if P1 cells are able to generate cartilage and bone like P0 cells 24 9 ( Figure 5 ). To this end, we performed 10 implantations of P1 cells (PLD 10). P1 cells 1 under PDL 12 exhibited cartilage formation with enchondral ossification after 2 implantation. The nodules at 25 weeks were composed of the perichondrium and 3 cartilage with accumulation of extracellular matrix ( Figure 5A vasculogenesis, adipogenesis and osteoclastogenesis were confirmed, however, bone 10 marrow cavity with differentiation into trabecular bone or mature adipocytes was not 11 detected. Type I collagen-positive matrix diffusely distributed at the perichondrium at 12 25 weeks ( Figure 5E ) and at the osteoid and new bone in the enchondral ossification at 13 41 weeks ( Figure 5K ). Vasculogenesis with CD 34-positive endothelia ( Figure 5F ) 14 started to be seen during enchondral ossification at 41 weeks ( Figure 5L ). 15 16 P1 cells (PDL 14) generated cartilage that were macroscopically flattened or 17 club-shaped, translucent and whitish surface, exhibited type II collagen-positive matrix 18 in the cartilage at 25 and 42 weeks after the implantation, but failed to develop bone 19 marrow even after follow-up observation ( Figure 6 ). The cartilage at 25 weeks level was 20 composed of small chondrocytes with round or spindle nuclei and lacunae, and 21 hypertrophic cells with large lacunae. The perichondrium showed the structure of thick 22 or thin layers with elongated fibroblast-like spindle cells ( Figure 6B ). The nodules at 42 23 weeks showed morphologies similar to those at 25 weeks, except decrease of 24 10 hypertrophic cells with large lacunae and slight increase of chondrocyte with spindle 1 nuclei and narrow lacunae in number, and increase in eosinophil of the perichondrial 2 matrix and in thickness of the perichondrium. Type-II collagen-positive matrix was 3 detected in the cartilage at 25 weeks ( Figure 6D ) and 42 weeks ( Figure 6I ). Type-I 4 collagen-positive matrix was distributed in the thick perichondrium at 25 weeks ( Figure  5 6E), and 42 weeks ( Figure 6J ). 6 7 In contrast, P2 cells also generated cartilage that was maintained for up to 17 weeks 8 ( Figure 7) . Macroscopically, the cartilage showed translucent and smooth, surface that 9 were white, partly light brown or yellow in color ( Figure 7A ). The cartilages at 9 weeks 10 consisted of hypertrophic chondrocytes with round or spindle nuclei and large lacunae 11 (Figure7B, C) . The cartilages at 17 weeks showed increase of small chondrocyte with 12 spindle nuclei and eosinophilic extracellular matrix at the perichondrium ( Figure 7G , H). 13
Type II collagen-positive matrix remained in the cartilage at 9 weeks ( Figure 7D ) and at 14 17 weeks ( Figure 7I ). Type-I collagen-positive matrix was distributed in the 15 perichondrium at 9 weeks ( Figure 7E ), and extended into the cartilage at 17 weeks, in 16 addition to the perichondrium ( Figure 7J ). 17
18
Lack of chondrogenic activity in P3 cells 19
P3 cells (PDL 23) generated fibrous tissue that was macroscopically translucent and 20 flattened, and tightly adhered to the subcutaneous tissue ( Figure 8A ). The tissue was 21 ill-defined in the boundaries between the perichondrium and cartilage ( Figure 8B , C). 22
Type II collagen-positive matrix was irregularly distributed in the cartilage ( Figure 8D ). 23
Type I collagen-positive matrix was irregularly found in the cartilage and not 24 overlapped with type II collagen-positive matrix ( Figure 8E ). 1 2 Discussion 3
For the cell-based therapeutic strategies of cartilage and bone formation, the expansion 4 of cultivation are required to gain sufficient number of cells, and to preserve for a long 5 period in recipient, therefore the detailed studies are essential with regards to the 6 characteristics of expanded and/or dedifferentiated chondrocytes in vitro and in vivo. 7
We have previously reported that chondrocytes from epiphyseal cartilage at a primary 8 culture have the ability to regenerate cartilage and to develop bone with marrow cavity 9 through enchondral ossification in vivo [2] . This present study demonstrated the 10 detailed alterations of the human infant epiphyseal chondrocytes during expansions 11 from P0 to P8 cells in monolayer culture and the ability of in vivo chondrogenesis and 12 osteogenesis by implantation, and long-term observation after implantation. 13
14
The fate of cartilage generated by chondrocytes depended on population doubling levels 15 of chondrocytes in culture. Primarily, implanted chondrocytes need to retain the abilities 16 to generate cartilage with production of type II collagen-positive cartilaginous matrix, 17 and to produce type I-positive perichondrium. In addition to chondrocytes, participation 18 of undifferentiated mesenchymal cells that differentiate to osteoblasts, adipocytes and 19 endothelia is required for bone development through enchondral ossification [1, 5, 6] . In 20 our previous study [2], we showed that perichondrial spindle cells participate in bone 21 development as undifferentiated mesenchymal cells after implantation of cultivated 22 chondrocytes, like perichondrial cells in a cartilage anlage of human embryonic bone. 23 24 12 Chondrogenic ability of cultivated chondrocytes is associated with surface markers, 1 gene expression, morphology, synthesis of the type of collagen and capacity of 2 redifferentiation, using human articular and other cartilages [7, 8] or animal [9] as cell 3 sources [10] [11] [12] . Surface markers include CD26 for the chondrogenic potential of 4 human articular chondrocytes [13] and ratio of CD54 to CD44 as an index of 5 differentiation status [7] . Morphology of chondrocytes changes from a differentiated 6 round to polygonal cell shape to dedifferentiated fibroblast-like phenotype [9, 14] . In 7 gene expression, type-II collagen is essential for chondrocytes capable of generating 8 cartilage [8] and inversely correlated with increasing PDLs [15] . The ratio of type-I and 9
type-II collagen, defined as an index of cell differentiation, is significantly higher at a 10 primary culture and become lower along with expansion [13] . in vivo chondrogenesis is 11 also associated with PDLs of cultivated chondrocytes in rabbit [16, 17] To reverse de-differentiation process during cultivation, several approaches have been 23 developed. Dedifferentiated chondrocytes after a longer cultivated period regain 24 13 chondrogenic activity by the high-density culture method [28] . To acquire sufficient cell 1 number for cartilage engineering, the co-culture system of in vitro-expanded 2 dedifferentiated chondrocytes with small numbers of primary chondrocyte is useful to 3 re-differentiate the de-differentiated cells and form thicker cartilage tissue with type-II 4 collagen [18] . Wnt/beta-catenin signaling may be involved in maintenance of 5 chondrogenic activity [29, 30] . Cultivation medium is shown to affect cell phenotypes 6 in vitro [31] . In addition to the re-differentiation strategies, the selection approach was 7 employed to isolate functionally active chondrogenic cells with high levels of type-II 8 collagen from dedifferentiated cells or hypertrophic cells with product of type-X 9 collagen for in vivo chondrogenesis [19] . Finally, the present studies showed the changes in cytology and gene expression of the 1 infant epiphyseal chondrocytes in a monolayer culture by cell expansion from the P0 to 2 P8 cells. The experiment in vivo by implantation of expanded cells for a short to long 3 periods demonstrated the fate of the epiphyseal chondrocytes and elucidated that the 4 proceeded passage-cells can regenerate the tissue for a short period; however these 5 tissues can't be preserved for a longer period and absorbed, except those of the P0 and 6 P1 cells. The bone development through enchondral ossification occurred in cartilage by 7 the P0 cells and by the P1 cells with only lower PDLs. The P1 cells with rather higher 8 PDLs form the articular cartilage-like tissue without ossification. These findings would 9 be a help of chondrocyte-based therapy. Hematoxylin and eosin (HE) stain, Toluidine blue (TB) stain, and immunohistochemical 5 analysis by using antibodies against vimentin, type II collagen (COL II), and type II 6 collagen (COL II) are shown from left to right. With TB stain, the extracellular matrix 7 of cartilage exhibited metachromasie diffusely in the nodules by P0 and P1 cells, and 8 focally in the nodules by P2 cells. The matrix of the nodules by P0 and P1 cells was 9 positive for COL II at the center and with type I collagen (COL I) at the periphery. The 10 nodule by P2 cells was focally COL II-positive and diffusely COL I-positive matrix. 11
The matrix in the nodules by P3 and P5 cells was not stained with COL II and showed 12 weakly positive reaction with COL I. The nodules by P7 cells were negative for COL II 13 and COL I. The microscopic views (the same as Figure 2C showed the flattened and smaller nodules (11 mg in weight) with translucent whitish 7 surface (A). Microscopic examination showed the cartilaginous tissue with tight 8 adhesion to the mouse muscle tissue and reactions of foreign-body type giant cells (B). 9
The nodule was consisted of chondrocytes with spindle nuclei and narrow lacunae and a 10 few hypertrophic cells (C) in myxomatous matrix. The matrix was focally positive for 11 COL II (D) and diffusely positive for COL I in the cartilage (E). 12 13 
